Sandoz announced this week that the Marketing Authorization Application (MAA) for its biosimilar to Amgen’s EU-licensed Neulasta (pegfilgrastim) has been accepted by the European Medicines Agency (EMA). Read More »

Pfizer Inc. has commended the United States Food and Drug Administration (FDA) Arthritis Advisory Committee for its recommendation to approve the biosimilar infliximab (CT-P13) this week. Read More »

Bristol-Myers Squibb and Pfizer announced this week that the companies have agreed to a cooperative effort with Portola Pharmaceuticals to develop and commercialize andexanet alpha. Read More »

Pomerantz LLP has announced that it has filed a class action lawsuit against GW Pharmaceuticals and specific officers within the company. Read More »

Market 32 by Price Chopper has announced its recent acquisition of O’Laughlin’s Home Care Pharmacy, located in Pittsfield, Massachusetts. Read More »

A recent article in the Wall Street Journal as well as analyst commentary noted that Pfizer Inc., Amgen Inc., Allergan PLC and others have hiked up dozens of U.S. drug prices since December, with many of the increases at nearly 9 percent and 10 percent. Read More »

Pfizer recently announced it is teaming up with Adaptive Biotechnologies to help advance its growing immuno-oncology pipeline. Read More »

Pfizer Inc. announced last week that its Research and Development investment strategy will be expanded to include companies in the initial phases of scientific advancements. Read More »

Novartis Pharmaceuticals revealed this week that it is collaborating with Qualcomm Life to develop the next generation of the Breezhaler inhaler for individuals with chronic obstructive pulmonary disease (COPD). Read More »

German drugmaker Merck KGaA and U.S. drug giant Pfizer revealed this week that they are collaborating with Syndax Pharmaceuticals to investigate avelumab as a combination treatment for advanced ovarian cancer.  Read More »

Pharmaceutical return services provider Guaranteed Returns recently introduced a new program that delivers quick payments to pharmacies. Read More »

German drugmaker Merck KGaA and American-based drug giant Pfizer recently initiated two new clinical trials involving the PD-L1 inhibitor known as avelumab.  Read More »

Kimberly Bartholomew was recently named the new GRx Hawaii regional account executive by Guaranteed Returns. Read More »

Democrat and Republican Senators criticized pharmaceutical companies Wednesday that have drastically hiked up the prices of life-saving medicines. Read More »

The Center for American Progress (CAP) recently submitted a proposal to improve Medicare by offering transparency in drug costs while reducing costs for consumers. Read More »

Bristol-Myers Squibb Foundation marked World AIDS Day Tuesday with $3.5 million in grants for HIV programs in Africa. Read More »

Immune Pharmaceutical, Inc. expanded its leadership team last week with the addition of two new hires. Read More »

U.S.-based drugmaker Pfizer said this week it is tackling the rising costs of prescription medicines head on by expanding its patient assistance program so that more people can gain access to free medicines. Read More »

Bristol-Myers Squibb has entered into a deal to acquire all issued and outstanding capital stock of Cardioxyl Pharmaceuticals, Inc. Read More »

The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb Company’s Opdivo (nivolumab) injection for the treatment of patients with metastatic, non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Read More »